Linda M Smith is a pharmacist who is specialized in Geriatric in Hagerstown, Maryland. Patients can reach her at 923 View St, Hagerstown or contact her on 301-733-2537. Active license number of Linda M Smith is 10755 for Geriatric in Maryland. Linda M Smith is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Linda M Smith speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Linda M Smith
Specialization:
Geriatric
Credentials:
RPH, CGP
Gender:
Female
Location:
923 View St, Hagerstown, Maryland, 21742-3962
Phone:
301-733-2537
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Linda M Smith are as mentioned below.
NPI Number:
1871796763
NPI Enumeration Date:
07 Jun, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Linda M Smith are as mentioned below.
Specialization
License Number
State
Status
Geriatric
10755
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
923 View St, Hagerstown, Maryland
Zip:
21742-3962
Phone Number:
301-733-2537
Fax Number:
--
Patients can reach Linda M Smith at 923 View St, Hagerstown, Maryland or can call on phone at 301-733-2537.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.